<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-35996" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Orbital Cellulitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Danishyar</surname>
            <given-names>Amina</given-names>
          </name>
          <aff>Midwestern University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sergent</surname>
            <given-names>Shane R.</given-names>
          </name>
          <aff>Michigan State University College of OM</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amina Danishyar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shane Sergent declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-35996.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Orbital cellulitis is defined as a serious infection that involves the muscle and fat located within the orbit. It is also sometimes referred to as postseptal cellulitis. Orbital cellulitis does not involve the globe itself. Although orbital cellulitis can occur at any age, it is more common in the pediatric population.The causative organisms of orbital cellulitis are commonly bacterial but can also be polymicrobial, often including aerobic and anaerobic bacteria and even fungal or mycobacteria. Orbital cellulitis is primarily diagnosed clinically by objective findings on physical examination combined with presenting signs and symptoms. The most important distinguishing feature of orbital cellulitis is the presence of ophthalmoplegia, the presence of pain with eye movement, and/or proptosis. Orbital cellulitis also typically cause eyelid swelling with or without erythema; however, these findings are also seen in another less serious condition called preseptal cellulitis. This activity reviews the cause, pathophysiology and presentation of orbital cellulitis and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of orbital cellulitis</p></list-item><list-item><p>Recall the causes of orbital cellulitis</p></list-item><list-item><p>List the treatment and management options available for orbital cellulitis</p></list-item><list-item><p>Discuss interprofessional team strategies for improving care coordination and communication to advance the treatment of orbital cellulitis and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=35996&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=35996">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-35996.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Orbital cellulitis is defined as a serious infection that involves the muscle and fat located within the orbit. It is also sometimes referred to as postseptal cellulitis. Orbital cellulitis does not involve the globe itself. Although orbital cellulitis can occur at any age, it is more common in the pediatric population<xref ref-type="bibr" rid="article-35996.r1">[1]</xref>.The causative organisms of orbital cellulitis are commonly bacterial but can also be polymicrobial, often&#x000a0;including aerobic and anaerobic bacteria and even fungal or mycobacteria. The most common bacterial organisms causing orbital cellulitis are <italic toggle="yes">Staphylococcus aureus</italic> and <italic toggle="yes">Streptococci</italic> species. Rare cases of orbital cellulitis caused by non-spore-forming anaerobes <italic toggle="yes">Aeromonas hydrophila</italic>, <italic toggle="yes">Pseudomonas aeruginosa</italic>, and <italic toggle="yes">Eikenella corrodens</italic> have also been reported<xref ref-type="bibr" rid="article-35996.r2">[2]</xref>. Fungal pathogens causing invasive orbital cellulitis include <italic toggle="yes">Mucorales</italic> which causes mucormycosis and <italic toggle="yes">Aspergillus</italic> which can cause life-threatening invasive orbital infections<xref ref-type="bibr" rid="article-35996.r3">[3]</xref>. In immunocompromised patients with orbital cellulitis, mucormycosis and invasive aspergillosis should be considered as the cause of orbital cellulitis. Mucormycosis affects patients with diabetic ketoacidosis as well as the patients with renal acidosis. <italic toggle="yes">Aspergillus</italic> infection of the orbit occurs in patients with severe neutropenia or other immune deficiencies, such as HIV infection. Other rare reported cause of orbital cellulitis is mycobacteria, especially <italic toggle="yes">Mycobacterium tuberculosis<xref ref-type="bibr" rid="article-35996.r3">[3]</xref>.</italic></p>
        <p>Orbital cellulitis is primarily diagnosed clinically by objective findings on physical examination combined with presenting signs and symptoms. The most important distinguishing feature of orbital cellulitis is the presence of ophthalmoplegia, the presence of pain with eye movement, and/or proptosis<xref ref-type="bibr" rid="article-35996.r2">[2]</xref>. Orbital cellulitis also typically cause eyelid swelling with or without erythema; however, these findings are also seen in another less serious condition called preseptal cellulitis.&#x000a0; The diagnosis of orbital cellulitis can be confirmed by imaging modalities such as Computed Tomography (CT) and Magnetic Resonance Imaging (MRI). Due to the controversy surrounding imaging use and the risks of radiation exposure to the pediatric population, there are guidelines and recommendation in place that highlight the indications and aid in the proper use of imaging for diagnosis of orbital cellulitis.</p>
        <p>Treatment of orbital cellulitis includes antibiotics and other supportive therapies. An ophthalmologist and otolaryngologist should also be consulted for proper examination and because, in some cases, surgery may be required. Without prompt diagnosis and proper treatment, the infection of the orbit can progress and extend to the adjacent anatomical locations and result in serious complications<xref ref-type="bibr" rid="article-35996.r2">[2]</xref>. Those complications include loss of vision, subperiosteal abscess, orbital abscess, and intracranial extension of the infection. The choice of antibiotics is broad spectrum regimens aimed at covering for organisms such as<italic toggle="yes"> S. aureus</italic> (including methicillin-resistant <italic toggle="yes">S. aureus</italic> [MRSA]), <italic toggle="yes">Streptococcus pneumoniae,</italic>&#x000a0;other <italic toggle="yes">Streptococci</italic>, as well as gram-negative bacilli. The antibiotic regimen should also include coverage for anaerobes when an intracranial extension is suspected. Antifungals are indicated only when a fungal infection is suspected in the appropriate clinical setting. Further details on specific antibiotics will be explained in the diagnosis section. Analgesics such as NSAIDs and acetaminophen can be used alone or in combination to achieve effective pain control in patients with orbital cellulitis.</p>
      </sec>
      <sec id="article-35996.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The most common cause of orbital cellulitis is bacterial rhinosinusitis. Other potential causes include<xref ref-type="bibr" rid="article-35996.r4">[4]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Infection of the teeth, middle ear, or face</p>
          </list-item>
          <list-item>
            <p>Dacryocystitis</p>
          </list-item>
          <list-item>
            <p>Orbital trauma with fracture or foreign body</p>
          </list-item>
          <list-item>
            <p>Ophthalmic surgery such as strabismus surgery, blepharoplasty, radial keratotomy and retinal surgery</p>
          </list-item>
          <list-item>
            <p>Peribulbar anesthesia</p>
          </list-item>
          <list-item>
            <p>An infected mucocele that erodes into the orbit</p>
          </list-item>
          <list-item>
            <p>Immunodeficiency</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-35996.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Orbital cellulitis is&#x000a0;commonly seen in young children. It is seen&#x000a0;less in older children and adults<xref ref-type="bibr" rid="article-35996.r5">[5]</xref>.</p>
      </sec>
      <sec id="article-35996.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Orbital cellulitis is a rare complication of bacterial rhinosinusitis. However, in most cases of orbital cellulitis, rhinosinusitis is the source of infection. Data show that in up to 86% to 98% of cases of orbital cellulitis, there is coexisting rhinosinusitis present. Moreover, pansinusitis and ethmoid sinusitis are the forms of rhinosinusitis that most likely to lead to orbital cellulitis.<xref ref-type="bibr" rid="article-35996.r6">[6]</xref></p>
      </sec>
      <sec id="article-35996.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The best indicators of orbital cellulitis is a pain with eye movements, proptosis, and ophthalmoplegia with diplopia. Chemosis (conjunctival swelling) is more commonly present in orbital cellulitis; however, it may also be seen occasionally in severe cases of preseptal cellulitis. Fever and peripheral leukocytosis with a predominance of neutrophils are also seen in orbital cellulitis. Eyelid erythema may or may not be present.<xref ref-type="bibr" rid="article-35996.r7">[7]</xref></p>
      </sec>
      <sec id="article-35996.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of orbital cellulitis should always begin with a physical exam looking for clinical findings of orbital cellulitis but also for its serious complications. It is important that an ophthalmologist&#x000a0;evaluate a patient with suspected orbital cellulitis for extraocular movements, visual acuity, and to assess for proptosis. In addition, an otolaryngologist should be consulted for evaluation of patients with extensive rhinosinusitis<xref ref-type="bibr" rid="article-35996.r7">[7]</xref>.</p>
        <p>
<bold>Laboratory Studies</bold>
</p>
        <p>Although low yield, it is recommended to obtain blood cultures for common bacterial pathogens and, depending on the circumstances, fungi and mycobacteria from patients with suspected orbital cellulitis prior to the administration of antibiotics.</p>
        <p>
<bold>Imaging Studies</bold>
</p>
        <p>Two main imaging tools are available such as a CT and MRI to aid in the diagnosis of orbital cellulitis. MRI has been found to be superior to CT scan because it can help in following soft tissue disease progression<xref ref-type="bibr" rid="article-35996.r8">[8]</xref>. However, due to lack of availability of MRI, CT scanning is more commonly used. Other specific imaging modalities such as MRI or CT venography are used when complications of orbital cellulitis are suspected. Based on the studies and guidelines it is recommended that patients with suspected orbital cellulitis with any of the following features undergo a contrast-enhanced CT scan of the orbits and sinuses<xref ref-type="bibr" rid="article-35996.r8">[8]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Proptosis</p>
          </list-item>
          <list-item>
            <p>Limitation of eye movements</p>
          </list-item>
          <list-item>
            <p>Pain with eye movements</p>
          </list-item>
          <list-item>
            <p>Double vision</p>
          </list-item>
          <list-item>
            <p>Vision loss</p>
          </list-item>
          <list-item>
            <p>Edema extending beyond the eyelid margin</p>
          </list-item>
          <list-item>
            <p>ANC greater than 10,000 cell/microL</p>
          </list-item>
          <list-item>
            <p>Signs or symptoms of central nervous system (CNS) involvement</p>
          </list-item>
          <list-item>
            <p>Inability to examine the patient fully (patients less than 1 year of age)</p>
          </list-item>
          <list-item>
            <p>Patients who do not begin to show improvement within 24 to 48 hours of initiating</p>
          </list-item>
        </list>
        <p>
<bold>
<italic toggle="yes">Findings on Imaging</italic>
</bold>
</p>
        <p>Common CT findings in orbital cellulitis are inflammation of extraocular muscles, fat stranding, and anterior displacement of the globe, although this may be subtle. Evidence of rhinosinusitis, with the most intense, is commonly seen in ethmoid sinuses. Complications of orbital cellulitis, for example, subperiosteal abscesses and orbital abscesses appear as low-density collections on CT scan.</p>
      </sec>
      <sec id="article-35996.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Uncomplicated orbital cellulitis can be treated with antibiotics alone. Treatment regimens are usually empiric and designed to address the most common pathogens as described above because reliable culture results are difficult to obtain in the absence of surgical intervention. For patients with uncomplicated orbital cellulitis, it is suggested that antibiotics be continued until all signs of orbital cellulitis have resolved. The duration of antibiotic therapy ranges from a total of at least 2 to 3 weeks. For patients with severe ethmoid sinusitis and bony destruction of the sinus, a longer period, at least 4 weeks is recommended<xref ref-type="bibr" rid="article-35996.r7">[7]</xref>.</p>
        <p>Appropriate antibiotic regimens for empiric treatment in patients with normal renal function include:</p>
        <p>
<bold>Intravenous (IV) Therapy</bold>
</p>
        <p>
<italic toggle="yes">
<bold>Vancomycin</bold>
</italic>
</p>
        <p>For MRSA coverage</p>
        <list list-type="bullet">
          <list-item>
            <p>Children: 40 to 60 mg/kg per day IV divided into 3 or 4 doses; Maximum daily dose 4 g</p>
          </list-item>
          <list-item>
            <p>Adults: 15 to 20 mg/kg per day IV every 8 to 12 hours; Maximum 2 g for each dose</p>
          </list-item>
        </list>
        <p>Plus&#x000a0;one of the following:</p>
        <p>
<italic toggle="yes">Ceftriaxone</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Children: 50 mg/kg per dose IV once or twice per day (the higher dose should be used if an intracranial extension is suspected); Maximum daily dose 4 g per day</p>
          </list-item>
          <list-item>
            <p>Adults: 2 g IV per day (2 g IV every 12 hours if an intracranial extension is suspected)</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Cefotaxime</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Children: 150 to 200 mg/kg per day in 3 doses; Maximum daily dose 12 g</p>
          </list-item>
          <list-item>
            <p>Adults: 2 g IV every 4 hours</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Ampicillin-sulbactam</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Children: 300 mg/kg per day in 4 divided doses; Maximum daily dose 8 g of the ampicillin component</p>
          </list-item>
          <list-item>
            <p>Adults: 3 g IV every 6 hours of the ampicillin-sulbactam combination</p>
          </list-item>
        </list>
        <p>P<italic toggle="yes">iperacillin-tazobactam</italic></p>
        <list list-type="bullet">
          <list-item>
            <p>Children: 240 mg/kg per day in 3 divided doses; Maximum daily dose 16 g of the piperacillin component</p>
          </list-item>
          <list-item>
            <p>Adults: 4.5 g IV every 6 hours of the piperacillin-tazobactam combination</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Metronidazole</italic>
</p>
        <p>Should be added to include coverage for anaerobes.</p>
        <list list-type="bullet">
          <list-item>
            <p>Adults: 500 mg IV or orally every 8 hours</p>
          </list-item>
          <list-item>
            <p>Children: 30 mg/kg per day IV or orally in divided doses every 6 hours</p>
          </list-item>
        </list>
        <p>Other agents that cover for MRSA infection are daptomycin, linezolid, and telavancin; however, there is little experience using them for orbital or intracranial infections. In the absence of a contraindication such an allergy, vancomycin is the preferred agent for MRSA coverage of orbital cellulitis. Linezolid is not recommended for children with CNS infections as its concentrations in the CNS have been inconsistent in children.</p>
        <p>In case of allergy to penicillins and/or cephalosporins, treatment with a combination of vancomycin plus:</p>
        <p>
<italic toggle="yes">Ciprofloxacin</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Adults: 400 mg IV twice per day or 500 to 750 mg orally twice per day</p>
          </list-item>
          <list-item>
            <p>Children: 20 to 30 mg/kg per day divided every 12 hours;&#x000a0;Maximum dose of 1.5 g orally daily or 800 mg IV daily</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Levofloxacin </italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Adults: 500 to 750 mg IV or orally daily</p>
          </list-item>
          <list-item>
            <p>Children 5 years or older: 10 mg/kg per dose every 24 hours; Maximum daily dose 500 mg</p>
          </list-item>
          <list-item>
            <p>Infants 6 months or older and children 5 years or younger: 10 mg/kg per dose every 12 hours</p>
          </list-item>
        </list>
        <p>
<bold>Oral Therapy</bold>
</p>
        <p>There are no controlled trials to define the ideal duration of antimicrobial therapy in orbital cellulitis or when to switch to oral treatment from intravenous. For uncomplicated orbital cellulitis with good response to IV antibiotics, it is reasonable to switch to oral therapy. If patient remains afebrile and the eyelid and orbital findings have begun to resolve substantially, which usually takes three to five days then switching to oral antibiotics is warranted. If definitive culture data are available, oral therapy should be directed against the infecting organisms. When there are no definitive culture data, appropriate empiric oral regimens include the following:</p>
        <p><italic toggle="yes"><bold>Clindamycin</bold>&#x000a0;</italic>(alone)</p>
        <list list-type="bullet">
          <list-item>
            <p>Adults: 300 mg Q8H</p>
          </list-item>
          <list-item>
            <p>Children: 30-40 mg/kg per day in 3 to 4 equally divided doses, not to exceed 1.8 g per day</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">
<bold>Clindamycin or Trimethoprim-Sulfamethoxazole</bold>
</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Adults: 1 to 2 DS tablets every 12 hours</p>
          </list-item>
          <list-item>
            <p>Children: 10 to 12 mg/kg per day of the trimethoprim component divided every 12 hours</p>
          </list-item>
        </list>
        <p>Plus one of the following:</p>
        <p>
<italic toggle="yes">Amoxicillin</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Adults: 875 mg orally every 12 hours</p>
          </list-item>
          <list-item>
            <p>Children: 45 mg/kg per day in divided doses every 12 hours or 80 to 100 mg/kg per day in divided doses every 8 hours; Maximum dose 500 mg per dose</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Amoxicillin-clavulanic</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Adults: 875 mg every 12 hours</p>
          </list-item>
          <list-item>
            <p>Children: 40 to 45 mg/kg per day in divided doses every 8 to 12 hours or 90 mg/kg per day divided every 12 hours (600 mg/5 mL suspension)</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Cefpodoxime</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Adults: 400 mg every 12 hours</p>
          </list-item>
          <list-item>
            <p>Children: 10 mg/kg per day divided every 12 hours, not to exceed 200 mg per dose</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Cefdinir</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Adults: 300 mg twice daily</p>
          </list-item>
          <list-item>
            <p>Children: 7 mg/kg twice daily, not to exceed 600 mg per day</p>
          </list-item>
        </list>
        <p>
<bold>Surgery</bold>
</p>
        <p>Surgery is almost always indicated in patients with intracranial extension of the infection. Other indications for surgery are poor or failure to respond to antibiotic therapy, worsening visual acuity or pupillary changes, or evidence of an abscess, especially a large abscess, greater than 10 mm in diameter. Smaller abscesses can be followed clinically and with repeat imaging unless impairment of vision is a concern. If either the clinical findings or CT scan show no improvement within 24 to 48 hours, surgical drainage is usually indicated. Surgery may also be indicated to obtain culture material, for example, in patients with suspected fungal or mycobacterial infection of the orbit. External approaches (through the orbit) and endoscopic transcaruncular surgery can be employed.</p>
      </sec>
      <sec id="article-35996.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Acute Complications of Sarcoidosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Adenoviral conjunctivitis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Carotid-cavernous fistula</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Langerhans cell histiocytosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Orbital Inflammatory Syndrome</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pediatric Mucormycosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Retinoblastoma</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Retrobulbar haemorrhage</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Sickle cell orbitopathy</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Thyroid Ophthalmopathy</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Widow Spider Envenomation</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-35996.s10" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>The outcomes of orbital cellulitis entirely depend on whether complications are present. For the most part, patients with orbital cellulitis respond quickly and completely to appropriate antibiotic therapy. Serious complications such as cavernous sinus thrombosis, intracranial extension, and vision loss can lead to permanent sequelae. Death is a rare but possible sequela of the complications of the orbital cellulitis<xref ref-type="bibr" rid="article-35996.r9">[9]</xref>.</p>
      </sec>
      <sec id="article-35996.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Orbital cellulitis is an ocular emergency that is best managed by an interprofessional team including pharmacists and nurses. The treatment of orbital cellulitis includes antibiotics and other supportive therapies. An ophthalmologist and otolaryngologist should also be consulted for proper examination and because, in some cases, surgery may be required. Without prompt diagnosis and proper treatment, the infection of the orbit can progress and extend to the adjacent anatomical locations and result in serious complications<xref ref-type="bibr" rid="article-35996.r2">[2]</xref>. Those complications include loss of vision, subperiosteal abscess, orbital abscess, and intracranial extension of the infection.</p>
        <p>The outcomes for simple and early cases is excellent but those with extension of the infection into the cranial cavity have a guarded prognosis.</p>
      </sec>
      <sec id="article-35996.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=35996&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=35996">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/orbital-cellulitis-eye-infection/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=35996">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/35996/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=35996">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-35996.s13">
        <title>References</title>
        <ref id="article-35996.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsirouki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dastiridou</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Ib&#x000e1;nez Flores</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cerpa</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Moschos</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Brazitikos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Androudi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Orbital cellulitis.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2018</year>
            <season>Jul-Aug</season>
            <volume>63</volume>
            <issue>4</issue>
            <fpage>534</fpage>
            <page-range>534-553</page-range>
            <pub-id pub-id-type="pmid">29248536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35996.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hamed-Azzam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>AlHashash</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Briscoe</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Verity</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Common Orbital Infections ~ State of the Art ~ Part I.</article-title>
            <source>J Ophthalmic Vis Res</source>
            <year>2018</year>
            <season>Apr-Jun</season>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>175</fpage>
            <page-range>175-182</page-range>
            <pub-id pub-id-type="pmid">29719647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35996.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sagiv</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Thakar</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Kandl</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Kontoyiannis</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Debnam</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Esmaeli</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Clinical Course of Preseptal and Orbital Cellulitis in 50 Immunocompromised Patients with Cancer.</article-title>
            <source>Ophthalmology</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>125</volume>
            <issue>2</issue>
            <fpage>318</fpage>
            <page-range>318-320</page-range>
            <pub-id pub-id-type="pmid">29128228</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35996.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>James</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mohamad Ikbal</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Min</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Ganapathy</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Periorbital Cellulitis in Paediatric Emergency Medicine Department Patients.</article-title>
            <source>Ann Acad Med Singap</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>47</volume>
            <issue>10</issue>
            <fpage>420</fpage>
            <page-range>420-423</page-range>
            <pub-id pub-id-type="pmid">30460969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35996.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iftikhar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Junaid</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lemus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mallick</surname>
                <given-names>ZN</given-names>
              </name>
              <name>
                <surname>Mina</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Hannan</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Canner</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Latif</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SMA</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Primary Ophthalmic Inpatient Admissions in the United States.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>185</volume>
            <fpage>101</fpage>
            <page-range>101-109</page-range>
            <pub-id pub-id-type="pmid">29101007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35996.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El Mograbi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ritter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Najjar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Soudry</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Orbital Complications of Rhinosinusitis in the Adult Population: Analysis of Cases Presenting to a Tertiary Medical Center Over a 13-Year Period.</article-title>
            <source>Ann Otol Rhinol Laryngol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>128</volume>
            <issue>6</issue>
            <fpage>563</fpage>
            <page-range>563-568</page-range>
            <pub-id pub-id-type="pmid">30788974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35996.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tzelnick</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Soudry</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Raveh</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gilony</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Recurrent periorbital cellulitis associated with rhinosinusitis in children: Characteristics, course of disease, and management paradigm.</article-title>
            <source>Int J Pediatr Otorhinolaryngol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>121</volume>
            <fpage>26</fpage>
            <page-range>26-28</page-range>
            <pub-id pub-id-type="pmid">30856372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35996.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Basraoui</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Elhajjami</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jalal</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>[Imaging of orbital cellulitis in children: about 56 cases].</article-title>
            <source>Pan Afr Med J</source>
            <year>2018</year>
            <volume>30</volume>
            <fpage>94</fpage>
            <pub-id pub-id-type="pmid">30344878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35996.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ru&#x000ed;z Carrillo</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>V&#x000e1;zquez Guerrero</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mercado Uribe</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>[Orbital cellulitis complicated by subperiosteal abscess due to Streptococcus pyogenes infection].</article-title>
            <source>Bol Med Hosp Infant Mex</source>
            <year>2017</year>
            <season>Mar-Apr</season>
            <volume>74</volume>
            <issue>2</issue>
            <fpage>134</fpage>
            <page-range>134-140</page-range>
            <pub-id pub-id-type="pmid">29382496</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
